Biocept Inc (BIOCQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Sales | 5,069 | 3,223 | 610 | 133 | 134 |
| Cost of Goods | 9,345 | 6,920 | 4,596 | 2,171 | 2,330 |
| Gross Profit | -4,277 | -3,697 | -3,986 | -2,037 | -2,196 |
| Operating Expenses | 17,243 | 15,248 | 13,021 | 12,007 | 6,079 |
| Operating Income | -21,175 | -18,025 | -16,411 | -13,874 | -7,944 |
| Interest Expense | 483 | 526 | 640 | 1,790 | 2,070 |
| Other Income | 51 | 154 | 102 | -201 | 782 |
| Pre-tax Income | -21,606 | -18,397 | -16,948 | -15,865 | -9,232 |
| Income Tax | 8 | -2 | 2 | 2 | 1 |
| Net Income Continuous | -21,614 | -18,395 | -16,950 | -15,866 | -9,233 |
| Net Income | $-21,614 | $-18,395 | $-16,950 | $-15,866 | $-9,233 |
| EPS Basic Total Ops | -7,081.08 | -17,314.61 | -27,685.34 | -107,415.40 | -1,374,485.00 |
| EPS Basic Continuous Ops | -7,081.19 | -17,319.23 | -27,725.66 | -107,380.20 | -1,374,436.00 |
| EPS Diluted Total Ops | -7,081.08 | -17,314.61 | -27,685.34 | -107,415.40 | -1,374,485.00 |
| EPS Diluted Continuous Ops | -7,081.19 | -17,319.23 | -27,725.66 | -107,380.20 | -1,374,436.00 |
| EPS Diluted Before Non-Recurring Items | -7,124.24 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-20,599 | $-17,703 | $-16,149 | $-13,623 | $-7,678 |